Ignite Creation Date:
2025-12-24 @ 6:55 PM
Ignite Modification Date:
2026-05-05 @ 8:55 AM
Study NCT ID:
NCT02465957
Status:
TERMINATED
Last Update Posted:
2024-05-02
First Post:
2015-06-03
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
QUILT-3.009: Patients With Stage III (IIIB) or Stage (IV) Merkel Cell Carcinoma (MCC)
Sponsor:
ImmunityBio, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
QUILT-3.009
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None